This chapter deals with some of the contentious court cases involving patent eligibility issues in life science areas in several countries, including the European Union (EU), USA, UK and India. Court cases on patent eligibility of thiopurine drugs to treat autoimmune diseases, diagnostic method for ...

This chapter focuses on the contemporary system of agricultural biotechnology innovation, which consists of a balance of exclusive and non-exclusive access to proprietary technologies to effectively support new crop development and the provision of both commercial growers and subsistence farmers...

This chapter focuses on Canada's novel approach to GM regulations. It discusses the recently adopted Agricultural Growth Act (AGA) which amends several key aspects of the Seeds Act and the Plant Breeders' Rights Act. The implications of AGA for intellectual property rights (IPRs), seed ownership...

This paper discusses recent patents regarding aspects of plant biotechnology pertaining to methodologies involved in the generation of transgenic crops and innovations that may improve human health. Procedures that can hasten the regulatory process for transgenic crops as well as technologies that...

This chapter focuses on the importance of the CRISPR/Cas9 system in genome editing. Some applications of this revolutionary genome editing system in the treatment of genetic disorders, infectious diseases, genetic engineering in plants, generation of animal models for research and laboratory...